 |
 |
|
|
|
| Voriconazole |
 |
| C16H14F3N5O |
 |
| 137234£62£9 |
 |
| Voriconazole is an antifungal, developed by Pfizer for the treatment of resistant systemic aspergillosis, resistant candidiasis, brain and eye infections and other emerging fungi seen in immunocompromised patients. |
 |
Items Specification
Description White to off-white crystalline powder
Melting Point 129.0¢¦132.0¡É
Specific Rotation -54¡Æ¢¦-59¡Æ
Related Impurity (HPLC) Single impurity: NMT 0.5%
Optical isomer: NMT 0.5%
Total impurity: NMT 1.0%
Assay NLT 98.5%
Content of Fluoride 14.7¢¦17.9%
|
| Industrial field |
cosmetics, pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
